Application of the Belle.AI Dermatological Image Reference System for Patient Diagnosis in an Active Clinical Setting
BelleTorus Corporation · with Urban Health Plan Inc. · NCT06724627
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Any age listed · All sexes
- Healthy volunteers
- Not accepted (a condition is required)
- Study type
- Interventional · Not applicable
- Target enrollment
- 263
- US sites recruiting
- 1
- Study start
- September 16, 2024
- Record last updated
- December 9, 2024
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
The goal of this research study is to test a new, investigational tool that uses artificial intelligence (AI) to help primary care providers assess skin conditions. This tool is an AI-powered dermatology image reference app that works with a smartphone. For clarity, the AI makes no diagnoses; it provides reference images. Primary care providers then use their own medical judgement and training to make the diagnosis.
The sponsor aims to compare the diagnoses made by primary care providers (such as doctors, nurse practitioners, and physician assistants) with the support of the AI tool compared to a panel of dermatologists, who are setting the gold standard. By doing so, the sponsor can determine the value of the AI tool for primary care providers and understand how it might be used alongside traditional clinical care.
This AI capability complies with FDA regulatory guidelines and is not considered a medical device, similar to a Google image search, which returns similar looking images for reference purposes. For intervention, they healthcare providers use their own training and clinical judgement to make the diagnosis, and not the AI.
Being studied: Dermatology/Skin - Other
Conditions: Skin Condition; Dermatology; Dermatology/Skin - Other
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- Patient must present to walk-in clinic with a primary dermatological complaint.
- Patient must have the ability and willingness to provide informed consent and comply with study procedures and visits.
- Participants must have access to the required technology (e.g., smartphone with internet access) and be capable of using it for the required image capture.
Exclusion Criteria
- Patients who are unable to comply with study procedures due to physical or mental health limitations (as assessed by study coordinator).
- Pediatric, adolescent, and teen patients who present with dermatological conditions on their genitalia will not be included in the study (in support of patient privacy concerns).
Recruiting US locations
Urban Health Plan Inc.
The Bronx, NY 07059
Site contact: Franco Barsanti, PharmD · 347-446-0227 · franco.barsanti@urbanhealthplan.org
Study contacts (from the official record)
- John Romano, MD · 617-520-4730 · jromano@belle.ai
- Franco Barsanti, PharmD · 347-446-0227 · franco.barsanti@urbanhealthplan.org